Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Haemonetics 3rd Quarter Fiscal 2020 Earnings Release Available on Investor Relations Website

HAE

Financial release accessible online

BOSTON, Feb. 4, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal 2020, which ended Dec. 28, 2019, are available on its Investor Relations website.

In addition, the Company is also posting the earnings release and results tables that will be referenced on its webcast.

Direct link to Earnings Release 3Q and YTD FY 20:

https://haemonetics.gcs-web.com/static-files/28d44ae0-77bd-466e-849c-d7e80649f964

Direct link to Results Tables 3Q and YTD FY 20 for reference on webcast conference call:

https://haemonetics.gcs-web.com/static-files/723e144b-2518-4289-8080-3b343725ba29

The Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8 a.m. ESTFeb. 4, 2020. The call can be accessed with the following information:

  • U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
  • Conference ID required for access: 1906607
  • A live webcast of the call can be accessed on Haemonetics' Investor Relations website.
  • Direct link to conference call webcast: https://edge.media-server.com/mmc/p/fuq43ous

ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our website at http://www.haemonetics.com.

Investor Contact

Media Contact

Olga Guyette, Director-Investor Relations

Carla Burigatto, VP-Communications

(781) 356-9763

(781) 348-7263

olga.guyette@haemonetics.com

carla.burigatto@haemonetics.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-3rd-quarter-fiscal-2020-earnings-release-available-on-investor-relations-website-300997903.html

SOURCE Haemonetics Corporation



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today